Funded Startups in Basel-Landschaft
Seven funded entries are listed for Basel-Landschaft across April 2020 to April 2026.
Seven funded entries are listed for Basel-Landschaft across April 2020 to April 2026. The largest disclosed round is Synendos Therapeutics’ $26M (2021-04-20), which dwarfs the other disclosed amounts in this set; even the next-largest disclosed figures are $4M (Qnami, 2021-05-11) and $3M (Spexis, 2023-08-15; Polyphor, 2020-11-24), with multiple undisclosed or lower-reported rounds at $640K (Cancentus, 2026-04-26). Sector clustering is visible: biotechnology accounts for four of the seven companies (Cancentus, BaseLaunch, Spexis, Qnami, Polyphor) while health care covers two (Spirecut; Synendos Therapeutics). Geographic concentration also appears, with Allschwil hosting the most entries (Cancentus, BaseLaunch, Spexis, Synendos Therapeutics, Polyphor), alongside Muttenz (Qnami; Spirecut). In the financing disclosures, four of seven entries show “Series Unknown” and one is explicitly “undisclosed,” limiting comparability of stage at the top of the timeline.
Most recent rounds
7 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Basel-Landschaft list, and how does it compare to the rest of the disclosed amounts?
Synendos Therapeutics’ $26M (2021-04-20) is the clear top disclosed round. The next-largest disclosed amounts are $4M (Qnami, 2021-05-11) and $3M (Spexis, 2023-08-15; Polyphor, 2020-11-24), while Cancentus is reported at $640K (2026-04-26).
Are there clusters by city or do the rounds spread evenly across Basel-Landschaft?
Allschwil is the dominant city in this set, appearing in Cancentus (2026-04-26), BaseLaunch, Spexis, Synendos Therapeutics, and Polyphor (2020-11-24). Muttenz appears for Qnami (2021-05-11) and Spirecut (2024-03-26), making it a smaller share of the listed companies.
Which entries fall in the most recent 90 days of the shown data?
Within the latest window ending at the most recent round date (2026-04-26, Cancentus), none of the other six entries are dated between 2026-01-27 and 2026-04-26. The next most recent date in the table is 2024-05-22 (BaseLaunch), followed by 2024-03-26 (Spirecut).
Does the sector mix lean toward biotechnology or health care in this list?
Biotechnology is over half of the entries, appearing in five of seven companies (Cancentus, BaseLaunch, Spexis, Qnami, Polyphor). Health care accounts for two of seven (Spirecut; Synendos Therapeutics).
How complete are the stage/amount disclosures, and is “Series Unknown” common here?
Disclosures are incomplete for multiple rows: four of seven entries list “Series Unknown” (Cancentus, BaseLaunch, Spexis, Polyphor), and one entry is “undisclosed” on amount (BaseLaunch). Amounts are explicitly disclosed for four of seven rows ($640K, $3M, $4M, and $26M across Cancentus, Spexis, Qnami, and Synendos Therapeutics).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.